Sonic Healthcare (STU:SAB) Other Long-Term Liabilities: €124 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:SAB Sonic Healthcare Ltd STU:SAB
72 GF Score
Price €11.90
GF Value €18.88
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare Other Long-Term Liabilities?

Sonic Healthcare STU:SAB -1.23% 72 Other Long-Term Liabilities is €124 Mil as of Jun. 2026. GuruFocus rates STU:SAB with a GF Score™ of 72/100 and a GF Value™ of €18.88 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Sonic Healthcare's other long-term liabilities for the quarter that ended in Jun. 2026 was €124 Mil.

Sonic Healthcare's quarterly other long-term liabilities increased from Jun. 2025 (€66 Mil) to Dec. 2025 (€150 Mil) but then declined from Dec. 2025 (€150 Mil) to Jun. 2026 (€124 Mil).

Sonic Healthcare's annual other long-term liabilities declined from Jun. 2024 (€131 Mil) to Jun. 2025 (€66 Mil) but then increased from Jun. 2025 (€66 Mil) to Jun. 2026 (€124 Mil).

Sonic Healthcare Other Long-Term Liabilities Related Terms

Sonic Healthcare Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Sonic Healthcare's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonic Healthcare Other Long-Term Liabilities Chart

Sonic Healthcare Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.44 79.29 130.92 66.16 123.51

Sonic Healthcare Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.92 136.98 66.16 149.65 123.51
STU:SAB
72GF Score
Sonic Healthcare Ltd STU:SAB
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonic Healthcare Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €124 Mil mean?
Sonic Healthcare (STU:SAB) has a Other Long-Term Liabilities of €124 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sonic Healthcare and its competitors.
Is Sonic Healthcare's Other Long-Term Liabilities too high?
Sonic Healthcare's current Other Long-Term Liabilities is €124 Mil. Overall, Sonic Healthcare has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonic Healthcare's Other Long-Term Liabilities compare to TMO and DHR?
Sonic Healthcare's Other Long-Term Liabilities of €124 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Diagnostics & Research company?
A good Other Long-Term Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sonic Healthcare and its competitors. Sonic Healthcare's current Other Long-Term Liabilities is €124 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sonic Healthcare (STU:SAB) is currently considered Significantly Undervalued. The stock's GF Value™ is €18.88, compared to a current price of €11.90 — trading 36.9% below its estimated fair value. The current Other Long-Term Liabilities is €124 Mil. Sonic Healthcare's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Sonic Healthcare (STU:SAB), the current Other Long-Term Liabilities is €124 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonic Healthcare (STU:SAB) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of €11.90 is trading 36.9% below its estimated GF Value™ of €18.88. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for STU:SAB:

  • Other Long-Term Liabilities: €124 Mil
  • GF Value™: €18.88 vs. price of €11.90 (36.9% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the STU:SAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
72GF Score

Get the complete analysis for STU:SAB

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.90
Price
€18.88
GF Value